Rainbow Childrens Medicare Limited (RAINBOW)
Investor Presentation
Investor Presentation - Q1 FY27
- Revenue 4,700 Mn +33% y-y; PAT 625 Mn +16% y-y; EBITDA margin ~30%
- Operational beds increased to 20,992 with occupancy at 41.2%, ARPOB slightly down 2%
- Expansion plan to increase total beds to 3,725 by FY29 across multiple cities
- Hub and Spoke model operational in Hyderabad and Bengaluru, expanding to Chennai and NCR
- Strong doctor engagement model with 1,075+ full-time doctors and largest pediatric DNB training
- JCI re-accreditation for flagship hospitals and fertility center
- Focus on multidisciplinary pediatric and perinatal care with advanced quaternary services
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 RAINBOW — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add RAINBOW to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Rainbow Childrens Medicare Limited
Important.
The summary above is generated automatically from Rainbow Childrens Medicare Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.